Literature DB >> 28818877

Neuropsychiatric adverse effects of montelukast in children.

Pierre Ernst1,2, Geneviève Ernst3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28818877     DOI： 10.1183/13993003.01020-2017

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  11 in total

1.  Canadian Thoracic Society 2012 guideline update: diagnosis and management of asthma in preschoolers, children and adults.

Authors:  M Diane Lougheed; Catherine Lemiere; Francine M Ducharme; Chris Licskai; Sharon D Dell; Brian H Rowe; Mark Fitzgerald; Richard Leigh; Wade Watson; Louis-Philippe Boulet
Journal:  Can Respir J       Date:  2012 Mar-Apr       Impact factor: 2.409

2.  Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial. Pediatric Montelukast Study Group.

Authors:  B Knorr; J Matz; J A Bernstein; H Nguyen; B C Seidenberg; T F Reiss; A Becker
Journal:  JAMA       Date:  1998-04-15       Impact factor: 56.272

3.  The added burden of comorbidity in patients with asthma.

Authors:  Tingting Zhang; Bruce C Carleton; Robert J Prosser; Anne M Smith
Journal:  J Asthma       Date:  2009-12       Impact factor: 2.515

4.  Neuropsychiatric adverse drug reactions in children initiated on montelukast in real-life practice.

Authors:  Brigitte Benard; Valérie Bastien; Benjamin Vinet; Roger Yang; Maja Krajinovic; Francine M Ducharme
Journal:  Eur Respir J       Date:  2017-08-17       Impact factor: 16.671

5.  Leukotriene antagonists as first-line or add-on asthma-controller therapy.

Authors:  David Price; Stanley D Musgrave; Lee Shepstone; Elizabeth V Hillyer; Erika J Sims; Richard F T Gilbert; Elizabeth F Juniper; Jon G Ayres; Linda Kemp; Annie Blyth; Edward C F Wilson; Stephanie Wolfe; Daryl Freeman; H Miranda Mugford; Jamie Murdoch; Ian Harvey
Journal:  N Engl J Med       Date:  2011-05-05       Impact factor: 91.245

6.  Inhaled corticosteroids in children with persistent asthma: effects on growth.

Authors:  Linjie Zhang; Sílvio O M Prietsch; Francine M Ducharme
Journal:  Evid Based Child Health       Date:  2014-12

7.  Excess medical costs in patients with asthma and the role of comorbidity.

Authors:  Wenjia Chen; Larry D Lynd; J Mark FitzGerald; Carlo A Marra; Robert Balshaw; Teresa To; Hamid Tavakoli; Mohsen Sadatsafavi
Journal:  Eur Respir J       Date:  2016-10-06       Impact factor: 16.671

8.  Montelukast reduces asthma exacerbations in 2- to 5-year-old children with intermittent asthma.

Authors:  Hans Bisgaard; Stefen Zielen; María Luz Garcia-Garcia; Sebastian L Johnston; Leen Gilles; Joris Menten; Carol A Tozzi; Peter Polos
Journal:  Am J Respir Crit Care Med       Date:  2004-11-12       Impact factor: 21.405

Review 9.  Addition of anti-leukotriene agents to inhaled corticosteroids in children with persistent asthma.

Authors:  Bhupendrasinh F Chauhan; Raja Ben Salah; Francine M Ducharme
Journal:  Cochrane Database Syst Rev       Date:  2013-10-02

10.  CNODES: the Canadian Network for Observational Drug Effect Studies.

Authors:  Samy Suissa; David Henry; Patricia Caetano; Colin R Dormuth; Pierre Ernst; Brenda Hemmelgarn; Jacques Lelorier; Adrian Levy; Patricia J Martens; J Michael Paterson; Robert W Platt; Ingrid Sketris; Gary Teare
Journal:  Open Med       Date:  2012-10-30
View more
  1 in total

1.  Montelukast and Nightmares: Further Characterisation Using Data from VigiBase.

Authors:  Sarah Watson; Elenor Kaminsky; Henric Taavola; Marian Attalla; Qun-Ying Yue
Journal:  Drug Saf       Date:  2022-06-01       Impact factor: 5.228
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.